1083
The main clinical features of this 58-year-old female patient were laboratory evidence of leucopenia and cholestasis, and biopsy features of fatty liver parenchyma degeneration with granulocytic portal infiltration and bile stasis, demonstrated 20 days after the initiation of antithyroid therapy with 20 mg methimazole daily.
 this 58-year-old female: Subject; 58-year-old: Subject.Age; female: Subject.Gender; leucopenia and cholestasis, and biopsy features of fatty liver parenchyma degeneration with granulocytic portal infiltration and bile stasis: Effect; antithyroid therapy with 20 mg methimazole daily: Treatment; 20 days after: Treatment.Time_elapsed; methimazole: Treatment.Drug; 20 mg: Treatment.Dosage; daily: Treatment.Freq
Given event type and trigger, please tell me the arguments of all the listed option. Output format is "name1: role1; name2: role2". 
Event type: adverse event 
  Option: Treatment.Freq, Subject.Population, Combination.Drug, Subject.Gender, Treatment.Duration, Subject, Effect, Treatment, Treatment.Disorder, Subject.Disorder, Treatment.Route, Subject.Race, Treatment.Time_elapsed, Treatment.Dosage, Subject.Age, Treatment.Drug 
Text: {0} 
Answer:
 this 58-year-old female: Subject; 58-year-old: Subject.Age; female: Subject.Gender; leucopenia and cholestasis, and biopsy features of fatty liver parenchyma degeneration with granulocytic portal infiltration and bile stasis: Effect; antithyroid therapy with 20 mg methimazole daily: Treatment; 20 days after: Treatment.Time_elapsed; methimazole: Treatment.Drug; 20 mg: Treatment.Dosage; daily: Treatment.Freq